Susceptibility to chronic thromboembolic pulmonary hypertension may be conferred by miR-759 via its targeted interaction with polymorphic fibrinogen alpha gene

Human Genetics

Volumn 128, Issue 4, 2010, Pages 443-452

  Chen, Zhiyong ^a   Nakajima, Toshiaki ^a   Tanabe, Nobuhiro ^b   Hinohara, Kunihiko ^a   Sakao, Seiichiro ^b   Kasahara, Yasunori ^b   Tatsumi, Koichiro ^b   Inoue, Yoshinori ^a   Kimura, Akinori ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; FIBRINOGEN ALPHA; MESSENGER RNA; MICRORNA; MIR 759; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; LUCIFERASE; MIRN759 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ADULT; AGED; ALLELE; ARTICLE; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; FGA GENE; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; HUMAN; INDEL MUTATION; LIVER; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; THROMBOEMBOLISM; CHRONIC DISEASE; COMPLICATION; GENE EXPRESSION; GENETIC PREDISPOSITION; GENETIC TRANSFECTION; GENETICS; HYPERTENSION, PULMONARY; LUNG EMBOLISM; METABOLISM; MIDDLE AGED; MUTATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

3' UNTRANSLATED REGIONS; ADULT; AGED; BLOTTING, WESTERN; CHRONIC DISEASE; FEMALE; FIBRINOGEN; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION, PULMONARY; LUCIFERASES; MALE; MICRORNAS; MIDDLE AGED; MUTATION; POLYMORPHISM, GENETIC; PULMONARY EMBOLISM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION;

EID: 77957596617     PISSN: 03406717     EISSN: 14321203     Source Type: Journal    
DOI: 10.1007/s00439-010-0866-8     Document Type: Article

References (30)

1. D Applegate L Haraga KM Hertzberg LS Steben JZ Zhang CM Redman G Grieninger 1998 The EC domains of human fibrinogen420 contain calcium binding sites but lack polymerization pockets Blood 92 3669 3674 1:CAS:528: DyaK1cXnsVKlsbk%3D 9808560
2. D Applegate LS Steben KM Hertzberg G Grieninger 2000 The alpha(E)C domain of human fibrinogen-420 is a stable and early plasmin cleavage product Blood 95 2297 2303 1:CAS:528:DC%2BD3cXitFeit74%3D 10733499
3. AM Carter AJ Catto HP Kohler RA Ariens MH Stickland PJ Grant 2000 Alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism Blood 96 1177 1179 1:CAS:528:DC%2BD3cXltlKiu7k%3D 10910940
4. CL Carty M Cushman D Jones LA Lange LA Hindorff K Rice NS Jenny JP Durda J Walston CS Carlson D Nickerson RP Tracy AP Reiner 2008 Associations between common fibrinogen gene polymorphisms and cardiovascular disease in older adults. The Cardiovascular Health Study Thromb Haemost 99 388 395 1:CAS:528: DC%2BD1cXisFKmt7s%3D 18278190 (Pubitemid 351230971)
5. PF Fedullo WR Auger KM Kerr LJ Rubin 2001 Chronic thromboembolic pulmonary hypertension N Engl J Med 345 1465 1472 1:STN:280: DC%2BD38%2FmsFGnug%3D%3D 10.1056/NEJMra010902 11794196
6. W Filipowicz SN Bhattacharyya N Sonenberg 2008 Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9 102 114 1:CAS:528:DC%2BD1cXnt1ensA%3D%3D 10.1038/nrg2290 18197166
7. Y Friedlander JD Kark R Sinnreich F Basso SE Humphries 2003 Combined segregation and linkage analysis of fibrinogen variability in Israeli families: evidence for two quantitative-trait loci, one of which is linked to a functional variant (-58G>A) in the promoter of the alpha-fibrinogen gene Ann Hum Genet 67 228 241 1:CAS:528:DC%2BD3sXnvVSqur4%3D 10.1046/j.1469-1809.2003.00016.x 12914575 (Pubitemid 38312829)
8. Y Fu JZ Zhang CM Redman G Grieninger 1998 Formation of the human fibrinogen subclass fib420: disulfide bonds and glycosylation in its unique (alphaE chain) domains Blood 92 3302 3308 1:CAS:528:DyaK1cXntFCqtro%3D 9787167
9. GM Fuller Z Zhang 2001 Transcriptional control mechanism of fibrinogen gene expression Ann N Y Acad Sci 936 469 479 1:CAS:528:DC%2BD3MXlsV2rt78%3D 10.1111/j.1749-6632.2001.tb03534.x 11460505
10. G Grieninger 2001 Contribution of the alpha EC domain to the structure and function of fibrinogen-420 Ann N Y Acad Sci 936 44 64 1:CAS:528: DC%2BD3MXlsV2rs74%3D 10.1111/j.1749-6632.2001.tb03493.x 11460498
11. MM Hoeper E Mayer G Simonneau LJ Rubin 2006 Chronic thromboembolic pulmonary hypertension Circulation 113 2011 2020 10.1161/CIRCULATIONAHA.105. 602565 16636189
12. K Jazdzewski EL Murray K Franssila B Jarzab DR Schoenberg A de la Chapelle 2008 Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma Proc Natl Acad Sci USA 105 7269 7274 1:CAS:528:DC%2BD1cXmsFCqsLo%3D 10.1073/pnas.0802682105 18474871 (Pubitemid 351754467)
13. YL Ko LA Hsu TS Hsu CT Tsai MS Teng S Wu CJ Chang YS Lee 2006 Functional polymorphisms of FGA, encoding alpha fibrinogen, are associated with susceptibility to venous thromboembolism in a Taiwanese population Hum Genet 119 84 91 1:CAS:528:DC%2BD28XhvVaqtrs%3D 10.1007/s00439-005-0102-0 16362348
14. S Kominami N Tanabe M Ota TK Naruse Y Katsuyama N Nakanishi H Tomoike M Sakuma K Shirato M Takahashi H Shibata M Yasunami Z Chen Y Kasahara K Tatsumi T Kuriyama A Kimura 2009 HLA-DPB1 and NFKBIL1 may confer the susceptibility to chronic thromboembolic pulmonary hypertension in the absence of deep vein thrombosis J Hum Genet 54 108 114 1:CAS:528:DC%2BD1MXktFClsbs%3D 10.1038/jhg.2008.15 19165231
15. G Le Gal B Delahousse K Lacut V Malaviolle S Regina MT Blouch F Couturaud D Mottier E Oger Y Gruel 2007 Fibrinogen Aalpha-Thr312Ala and factor XIII-A Val34Leu polymorphisms in idiopathic venous thromboembolism Thromb Res 121 333 338 1:CAS:528:DC%2BD1cXlvFShsw%3D%3D 10.1016/j.thromres.2007.05.003 17568659
16. M Levi TT Keller E van Gorp H ten Cate 2003 Infection and inflammation and the coagulation system Cardiovasc Res 60 26 39 1:CAS:528: DC%2BD3sXns12ktb4%3D 10.1016/S0008-6363(02)00857-X 14522404 (Pubitemid 38373473)
17. VK Lishko VP Yakubenko KM Hertzberg G Grieninger TP Ugarova 2001 The alternatively spliced alpha(E)C domain of human fibrinogen-420 is a novel ligand for leukocyte integrins alpha(M)beta(2) and alpha(X)beta(2) Blood 98 2448 2455 1:CAS:528:DC%2BD3MXnslCqsrc%3D 10.1182/blood.V98.8.2448 11588042
18. HF Lodish B Zhou G Liu CZ Chen 2008 Micromanagement of the immune system by microRNAs Nat Rev Immunol 8 120 130 1:CAS:528:DC%2BD1cXhtVGis70%3D 10.1038/nri2252 18204468 (Pubitemid 351161305)
19. K Lv Y Guo Y Zhang K Wang Y Jia S Sun 2008 Allele-specific targeting of hsa-miR-657 to human IGF2R creates a potential mechanism underlying the association of ACAA-insertion/deletion polymorphism with type 2 diabetes Biochem Biophys Res Commun 374 101 105 1:CAS:528:DC%2BD1cXptVGqt7Y%3D 10.1016/j.bbrc.2008.06.102 18602895
20. J Ma CH Hennekens PM Ridker MJ Stampfer 1999 A prospective study of fibrinogen and risk of myocardial infarction in the Physicians' Health Study J Am Coll Cardiol 33 1347 1352 1:STN:280:DyaK1M3gvVSrsg%3D%3D 10.1016/S0735- 1097(99)00007-8 10193737
21. JT Mendell 2008 miRiad roles for the miR-17-92 cluster in development and disease Cell 133 217 222 1:CAS:528:DC%2BD1cXltlWnurY%3D 10.1016/j.cell.2008.04. 001 18423194 (Pubitemid 351508308)
22. MW Mosesson KR Siebenlist DA Meh 2001 The structure and biological features of fibrinogen and fibrin Ann N Y Acad Sci 936 11 30 1:CAS:528:DC%2BD3MXlsV2rsrY%3D 10.1111/j.1749-6632.2001.tb03491.x 11460466
23. LJ Rasmussen-Torvik M Cushman MY Tsai Y Zhang SR Heckbert WD Rosamond AR Folsom 2007 The association of alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism in the LITE study Thromb Res 121 1 7 1:CAS:528: DC%2BD2sXht1Krsb%2FJ 10.1016/j.thromres.2007.02.008 17433418 (Pubitemid 350025992)
24. JA Remijn R van Wijk PG de Groot WW van Solinge 2001 Nature of the fibrinogen Aalpha gene TaqI polymorphism Thromb Haemost 86 935 936 1:CAS:528:DC%2BD3MXnsVeisr8%3D 11583334
25. B Siegerink FR Rosendaal A Algra 2009 Genetic variation in fibrinogen; its relationship to fibrinogen levels and the risk of myocardial infarction and ischemic stroke J Thromb Haemost 7 385 390 1:CAS:528:DC%2BD1MXktlGnsL0%3D 10.1111/j.1538-7836.2008.03266.x 19143925
26. KF Standeven PJ Grant AM Carter T Scheiner JW Weisel RA Ariens 2003 Functional analysis of the fibrinogen Aalpha Thr312Ala polymorphism: effects on fibrin structure and function Circulation 107 2326 2330 1:CAS:528: DC%2BD3sXjsVWjtL8%3D 10.1161/01.CIR.0000066690.89407.CE 12707238 (Pubitemid 36578503)
27. J Suntharalingam K Goldsmith V van Marion L Long CM Treacy F Dudbridge MR Toshner J Pepke-Zaba JC Eikenboom NW Morrell 2008 Fibrinogen Aalpha Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension Eur Respir J 31 736 741 1:CAS:528:DC%2BD1cXlsFyjsrg%3D 10.1183/09031936.00055107 18057060
28. N Tanabe A Kimura S Amano O Okada Y Kasahara K Tatsumi M Takahashi H Shibata M Yasunami T Kuriyama 2005 Association of clinical features with HLA in chronic pulmonary thromboembolism Eur Respir J 25 131 138 1:CAS:528: DC%2BD2MXhtFGhsrY%3D 10.1183/09031936.04.00042304 15640334 (Pubitemid 40207742)
29. H Tang Y Fu S Zhan Y Luo 2009 Alpha(E)C, the C-terminal extension of fibrinogen, has chaperone-like activity Biochemistry 48 18 3967 3976 1:CAS:528:DC%2BD1MXjslWmur8%3D 10.1021/bi900015n 19284787
30. K Yokoyama XP Zhang L Medved Y Takada 1999 Specific binding of integrin alpha v beta 3 to the fibrinogen gamma and alpha E chain C-terminal domains Biochemistry 38 5872 5877 1:CAS:528:DyaK1MXitlaht7k%3D 10.1021/bi9827619 10231539 (Pubitemid 29220609)